Recently, biology professor Anding Shen landed a $300, 000 grant from the National Institutes of Health (NIH) to study the role of endothelial cells in HIV infection—a project that will occupy her for ...

Antiretroviral therapy, the standard treatment for HIV, can remove any trace of the virus from the blood, but a hidden reservoir of HIV persists in patients who are in treatment. That means patients ...

Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective antiretroviral therapy, immune cells infected with HIV can hide and lie inactive ...

Human immunodeficiency viruses (HIV) are insidious. They can evade the immune defense and antiviral drugs by becoming "latent." In this state, they are largely invisible and unassailable. As long as ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. We might be a step closer to curing HIV, as researchers have developed ...

Now, researchers led by B. Matija Peterlin and colleagues at the Rosalind Russell Medical Research Center at the University of California, San Francisco have found two mechanisms that, at least ...

The key obstacle against the cure of human and simian immunodeficiency virus (HIV/SIV) infections is the reservoir of proviruses, which are robustly incorporated into the genomes of host CD4+ T cells.

Rebound DNA sequences from the blood (red) and the CSF (blue) [Swanstrom Lab, UNC School of Medicine] HIV’s ability to lay dormant, during suppressive antiviral therapy, is a major barrier to a cure.